Back to Search
AZZA BAKKAR, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1447887500IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2020
Research & Publications (4)
Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation.
PMID 16675591·Clin Cancer Res·2006
8-other
Sensitive allele-specific PCR assay able to detect FGFR3 mutations in tumors and urine from patients with urothelial cell carcinoma of the bladder.
PMID 16040860·Clin Chem·2005
8-other
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.
PMID 15347601·Carcinogenesis·2005
8-other
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.
PMID 14678961·Cancer Res·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE
NEW YORK, NY 10016 - Phone
- (917) 971-0574
Quick Facts
- NPI
- 1447887500
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 4
Are you this provider?
Claim Your Profile